Table 5
Author, date and countryPatient groupStudy type (level of evidence)OutcomesKey resultsStudy weaknesses
Kanter RK et al, 1986, USA,Phase 1: threeyear surveillance in paediatric ICU of 161 catheters (49 femoral) (one third of children under 10 kg) Phase 2: 29 paediatric patients needing central line had femoral line 77% had Ultrasound evaluation for thrombusCohort studyPhase 1 complicationsFemoral line: 6.1% complication rate including three leg swellings Neck sites: 4.5% complication rate, including two arm swellingsPoor gold standard for excluding thrombus as no children received ultrasound scanning or other imaging to look for thrombus, even if their leg swelled
Phase 2 complicationsLeg swelling in four patients and one thrombus around catheter at necropsy (11% adverse incident rate)Also 14% arterial puncture rate
Trottier SJ et al, 1995,45 patients in a medical and surgical ICUPRCTThrombotic complicationsUpper access sites: 0 of 21 positive ultrasound findingsThe USS examination did not look at the upper extremity deep veins
Randomised to upper or lower central line placement Ultrasonography performed before insertion, after removal and 7 days after removalFemoral access sites: 6 of 25 had DVT clinically and an additional 7 of 25 had USS findings of thrombosisThere were seven more triple lumen catheters inserted into the femoral vein than single lumen catheters, compared with upper access sites
Shefler A et al, 1995, Australia56 femoral lines in 54 children in a general paediatric ICU. Mean age 36 months range 0–192 months All patients had USS examination within three days of insertion and repeated every two to four daysProspective cohort studyThrombotic complicationsIVC thrombosis was found in 6 of 56 children (10.6%). All six were found on, or after 8 days of insertion. Thromboses found on day: 8, 8, 10, 20, and 20. Only one patient showed clinical signsSmall uncontrolled cohort No attempt to look at USS of lower limb deep veins May not be applicable to adult or older child groups
Durbec O et al, 1997, France80 consecutive patients undergoing femoral central line in a single adult ICUObservational cohort studyThrombotic complicationsNo clinical signs of DVTs or PEs seen, but on phlebography 34% of patients had DVT and 25% popliteal thrombosisNo power study performed.Uncontrolled study
Durbec O et al, 1997, France61 ICU patients undergoing either femoral venous catheterisation (31) or internal jugular (10) or axillary vein (21) cannulationPRCTThrombotic complications PhlebographyNo patient had clinical signs of a DVT or PE Fibrin sleeve seen in 23% of femoral group and none in SVC group. Two femoral vein thromboses seen in femoral group and one femoral vein thrombosis in the SVC cannula groupAxillary vein cannulation is an atypical site to use as a control group
Bilateral leg phlebography performed on removalNo power calculations, underpowered study
Timsit JF et al, 1999, France336 patients in three intensive care unitsPRCTTime for insertion15 min for non-tunnelled line and 25 min for tunnelled line92% were ventilated
Randomly assigned to tunnelled or non-tunnelled femoral venous catheterThrombotic complications7 DVTs
10 cm tunnel was used
Joynt GM et al, 2000, Hong Kong140 patients in an intensive care unit, all receiving a femoral line Duplex ultrasound performed before insertion, 12 hours after insertion, and then daily until removalCohort studyThrombotic complications12 iliofemoral DVTs found in cannulated leg 2 found in uncannulated leg Positive findings were not related to coagulation status, attempts at insertion, duration of catheterisation, or heparin bonded line useNo control group to compare the types of complication found with subclavian line, for example, pneumothorax, but otherwise a well conducted study
Merrer J et al, 2001, France289 adult patients in eight intensive care units receiving first central line Randomly assigned to femoral insertion (n = 145) or subclavian insertion (n = 144)PRCTThrombotic complicationsUSS detected Femoral 21.5% Subclavian 1.9%, p<0.01 Major thrombosis: femoral 6% subclavian 0%Thrombotic complications only assessed in 76% of patients, (but reasons for all of these were accounted for) Otherwise well conducted study